Information for "Drug focusing on CYP2E1 for the treatment earlystage alcohol addiction steatohepatitis"
Basic information
| Display title | Drug focusing on CYP2E1 for the treatment earlystage alcohol addiction steatohepatitis |
| Default sort key | Drug focusing on CYP2E1 for the treatment earlystage alcohol addiction steatohepatitis |
| Page length (in bytes) | 3,583 |
| Page ID | 1256003 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | 170.83.177.104 (talk) |
| Date of page creation | 15:13, 22 December 2022 |
| Latest editor | 170.83.177.104 (talk) |
| Date of latest edit | 15:13, 22 December 2022 |
| Total number of edits | 1 |
| Total number of distinct authors | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
